Joan Montero

11PUBLICATIONS
46CO-AUTHORS
Molecular targetsCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 03, 2024
HRK downregulation and augmented BCL-xL binding to BAK confer apoptotic protection to therapy-induced senescent melanoma cells.

Clara Alcon, Marta Kovatcheva, Paula Morales-Sánchez

|Nov 12, 2024
Nuclear IMPDH2 controls the DNA damage response by modulating PARP1 activity.

Lorena Espinar, Marta Garcia-Cao, Alisa Schmidt

|Dec 01, 2022
Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacy.

Albert Manzano-Muñoz, José Yeste, María A Ortega

|May 02, 2022
Adapted to Survive: Targeting Cancer Cells with BH3 Mimetics.

Joan Montero, Rizwan Haq

|Apr 08, 2022
MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment.

Clara Alcon, Fernando Martín, Estela Prada

Pageof 2